Sepantronium Bromide for the Treatment of High-grade B-cell Lymphoma

计划入组 14 人 · 首次发布于 2022 年 3 月 2 日

R-BL-M-04 Versus R-(DA)-EPOCH and Autologous Stem Cells Transplantation in Patients With High-Grade B-cell Lymphoma Double-hit (HGBL DH) and High-Grade B-cell Lymphoma Not Otherwise Specified (HGBL NOS)

计划入组 80 人 · 首次发布于 2018 年 3 月 27 日

Mosunetuzumab With Chemotherapy for the Treatment of Patients With Untreated C-Myc Rearrangement Positive High Grade B Cell Lymphoma or Diffuse Large B Cell Lymphoma

计划入组 40 人 · 首次发布于 2024 年 2 月 8 日

B cell High Density Microparticles (BioTransplant)

deubiquitinating enzyme inhibitor (B-Cell lymphoma)

B Cell lymphoma vaccine(Genitope Corp.)

AUSTRALASIAN LEUKAEMIA & LYMPHOMA GROUP

Australia

CIBC CANADIAN HIGH DIVIDEND COVERED CANADIAN HIGH DIVIDEND COVERED CALL ETF

India

HIGH POINT UNIVERSITY

United States

ViPOR Regimen Shows Durable Remissions in Relapsed DLBCL Subtypes

Epcoritamab Demonstrates Durable 3-Year Remissions in Relapsed/Refractory Large B-Cell Lymphoma

Roche's Glofitamab Expands Treatment Horizons for Multiple B-Cell Lymphomas